Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

Stephanie Kruetzmann, M Manuela Rosado, Holger Weber, Ulrich Germing, Olivier Tournilhac, Hans-Hartmut Peter, Reinhard Berner, Anke Peters, Thomas Boehm, Alessandro Plebani, Isabella Quinti, Rita Carsetti, Stephanie Kruetzmann, M Manuela Rosado, Holger Weber, Ulrich Germing, Olivier Tournilhac, Hans-Hartmut Peter, Reinhard Berner, Anke Peters, Thomas Boehm, Alessandro Plebani, Isabella Quinti, Rita Carsetti

Abstract

Splenectomized and asplenic patients have a high incidence of infections by encapsulated bacteria and do not respond to polysaccharide vaccines. To understand whether the absence of the spleen is associated with a defined B cell defect, we analyzed B cell subsets in the peripheral blood. We found that a population of B cells known as immunoglobulin (Ig)M memory is lacking in patients without spleen. The absence of IgM memory B cells correlates with an impaired immune response to encapsulated bacteria not only in splenectomized patients, but also in individuals with an intact spleen. We show that the physiological and transient predisposition to pneumococcal infections of young children (0-2 yr) is associated with the lack of circulating IgM memory B cells and of serum antipolysaccharide IgM. We also demonstrate that IgM memory B cells are undetectable in a fraction of patients with common variable immunodeficiency, who have recurrent and invasive infections by encapsulated bacteria. IgM memory B cells, therefore, require the spleen for their generation and/or survival and are responsible for the protection against encapsulated bacteria.

Figures

Figure 1.
Figure 1.
(A) Phenotypic analysis of B cells in the human peripheral blood. Donor PBLs were stained with Abs to CD22, CD27, IgM, and IgD and analyzed by four-color flow cytometry. Data is presented as density plots. CD22+ B cells were separated into CD27+ memory B cells (60%) and CD27− mature B cells (40%; left). In the right panels, IgD and IgM staining of all cells in the lymphocyte gate and of mature and memory B cells, identified as indicated in the left panel, is shown. Mature B cells are IgM+ IgDbright. Two populations of memory B cells can be identified, IgMbright IgDdull IgM memory B cells and switched memory B cells lacking the expression of both IgM and IgD. (B) Frequency of CD5+ B cells in the mature and memory compartments of eight donors. The expression of CD5 in IgM and switched memory B cells was calculated based on the staining for CD22, CD27, IgM, and CD5.
Figure 1.
Figure 1.
(A) Phenotypic analysis of B cells in the human peripheral blood. Donor PBLs were stained with Abs to CD22, CD27, IgM, and IgD and analyzed by four-color flow cytometry. Data is presented as density plots. CD22+ B cells were separated into CD27+ memory B cells (60%) and CD27− mature B cells (40%; left). In the right panels, IgD and IgM staining of all cells in the lymphocyte gate and of mature and memory B cells, identified as indicated in the left panel, is shown. Mature B cells are IgM+ IgDbright. Two populations of memory B cells can be identified, IgMbright IgDdull IgM memory B cells and switched memory B cells lacking the expression of both IgM and IgD. (B) Frequency of CD5+ B cells in the mature and memory compartments of eight donors. The expression of CD5 in IgM and switched memory B cells was calculated based on the staining for CD22, CD27, IgM, and CD5.
Figure 2.
Figure 2.
(A) Frequency of IgM and switched memory B cells in 11 controls and 14 splenectomized patients. (B) PBLs from the indicated subjects were stained and analyzed as described in Fig. 1 A. On the top, the expression of CD22 and CD27 is shown. The numbers indicate the frequency of memory B cells, calculated as a percentage of CD22+ B cells. On the bottom, IgM and switched memory B cells were identified as described in Fig. 1 A.
Figure 2.
Figure 2.
(A) Frequency of IgM and switched memory B cells in 11 controls and 14 splenectomized patients. (B) PBLs from the indicated subjects were stained and analyzed as described in Fig. 1 A. On the top, the expression of CD22 and CD27 is shown. The numbers indicate the frequency of memory B cells, calculated as a percentage of CD22+ B cells. On the bottom, IgM and switched memory B cells were identified as described in Fig. 1 A.
Figure 3.
Figure 3.
(A) Frequency of memory B cells in children. PBLs from 0–7-yr-old healthy children were stained and analyzed as described in Fig. 1 A. The frequency of CD22+ CD27+ memory B cells as a percentage of total CD22+ B cells is shown. The age in months is indicated on the x axis. (B) The level of total IgM in eight children of different ages and in one adult control were measured by ELISA and compared with the concentration of IgM specific for pneumococcal polysaccharide serotype 22. Total IgM is indicated by • (scale on the right y axis in micrograms/ml) and polysaccharide-specific IgM is indicated by the columns (scale in OD on the left y axis). The age in months is shown on the x axis. (C) Flow cytometric analysis of PBL from three asplenic and three control children. Samples were stained and analyzed as described in Fig. 1 A. The density plots show the CD22 and CD27 distribution. The frequency of memory B cells (as a percentage of total B cells) and the age of the children are indicated.
Figure 3.
Figure 3.
(A) Frequency of memory B cells in children. PBLs from 0–7-yr-old healthy children were stained and analyzed as described in Fig. 1 A. The frequency of CD22+ CD27+ memory B cells as a percentage of total CD22+ B cells is shown. The age in months is indicated on the x axis. (B) The level of total IgM in eight children of different ages and in one adult control were measured by ELISA and compared with the concentration of IgM specific for pneumococcal polysaccharide serotype 22. Total IgM is indicated by • (scale on the right y axis in micrograms/ml) and polysaccharide-specific IgM is indicated by the columns (scale in OD on the left y axis). The age in months is shown on the x axis. (C) Flow cytometric analysis of PBL from three asplenic and three control children. Samples were stained and analyzed as described in Fig. 1 A. The density plots show the CD22 and CD27 distribution. The frequency of memory B cells (as a percentage of total B cells) and the age of the children are indicated.
Figure 3.
Figure 3.
(A) Frequency of memory B cells in children. PBLs from 0–7-yr-old healthy children were stained and analyzed as described in Fig. 1 A. The frequency of CD22+ CD27+ memory B cells as a percentage of total CD22+ B cells is shown. The age in months is indicated on the x axis. (B) The level of total IgM in eight children of different ages and in one adult control were measured by ELISA and compared with the concentration of IgM specific for pneumococcal polysaccharide serotype 22. Total IgM is indicated by • (scale on the right y axis in micrograms/ml) and polysaccharide-specific IgM is indicated by the columns (scale in OD on the left y axis). The age in months is shown on the x axis. (C) Flow cytometric analysis of PBL from three asplenic and three control children. Samples were stained and analyzed as described in Fig. 1 A. The density plots show the CD22 and CD27 distribution. The frequency of memory B cells (as a percentage of total B cells) and the age of the children are indicated.
Figure 4.
Figure 4.
Our model on the origin and function of mature and IgM memory B cells. IgM memory B cells might be able to migrate to sites of inflammation and recognize invading pathogens through the B cell receptor (BCR) and possibly other pathogen-binding coreceptors. Switched memory B cells are generated from bone marrow–derived mature B cells after somatic mutation and class switch in the germinal centers.

References

    1. Davidson, R.N., and R.A. Wall. 2001. Prevention and management of infections in patients without a spleen. Clin. Microbiol. Infect. 7:657–660.
    1. Feder, H.M., Jr., and H.A. Pearson. 1999. Assessment of splenic function in familial asplenia. N. Engl. J. Med. 341:210–212.
    1. Hosea, S.W., C.G. Burch, E.J. Brown, R.A. Berg, and M.M. Frank. 1981. Impaired immune response of splenectomised patients to polyvalent pneumococcal vaccine. Lancet. 1:804–807.
    1. Stansfield, S.K. 1987. Acute respiratory infections in the developing world: strategies for prevention, treatment and control. Pediatr. Infect. Dis. J. 6:622–629.
    1. Overturf, G.D. 2002. Pneumococcal vaccination of children. Semin. Pediatr. Infect. Dis. 13:155–164.
    1. Spickett, G.P., J. Farrant, M.E. North, J.G. Zhang, L. Morgan, and A.D. Webster. 1997. Common variable immunodeficiency: how many diseases? Immunol. Today. 18:325–328.
    1. Quinti, I., A. Velardi, S. Le Moli, E. Guerra, R. D'Amelio, P. Mastrantonio, M.F. Martelli, and F. Aiuti. 1990. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation. J. Clin. Immunol. 10:160–166.
    1. Nitschke, L., R. Carsetti, B. Ocker, G. Kohler, and M.C. Lamers. 1997. CD22 is a negative regulator of B-cell receptor signalling. Curr. Biol. 7:133–143.
    1. Klein, U., K. Rajewsky, and R. Kuppers. 1998. Human immunoglobulin (Ig)M+ IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188:1679–1689.
    1. Hayakawa, K., and R.R. Hardy. 2000. Development and function of B-1 cells. Curr. Opin. Immunol. 12:346–353.
    1. Germing, U., C. Perings, S. Steiner, A.J. Peters, M.P. Heintzen, and C. Aul. 1999. Congenital asplenia detected in a 60 year old patient with septicemia. Eur. J. Med. Res. 4:283–285.
    1. Chanet, V., O. Tournilhac, V. Dieu-Bellamy, N. Boiret, P. Spitz, O. Baud, C. Darcha, P. Travade, and H. Laurichesse. 2000. Isolated spleen agenesis: a rare cause of thrombocytosis mimicking essential thrombocythemia. Haematologica. 85:1211–1213.
    1. Heller, R.E., and S.K. Fernbach. 2000. Two apparent suprarenal masses. Two cases in children: heterotaxy syndrome with spleen lying in suprarenal space and gastric duplication cyst lying in suprarenal space. Pediatr. Radiol. 30:400–403.
    1. Ochsenbein, A.F., T. Fehr, C. Lutz, M. Suter, F. Brombacher, H. Hengartner, and R.M. Zinkernagel. 1999. Control of early viral and bacterial distribution and disease by natural antibodies. Science. 286:2156–2159.
    1. Forster, I., and K. Rajewsky. 1987. Expansion and functional activity of Ly-1+ B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur. J. Immunol. 17:521–528.
    1. Ochs, H.D., S.H. Fischer, M.L. Lee, E.S. Delson, H.S. Kingdon, and R.J. Wedgwood. 1986. Intravenous immunoglobulin home treatment for patients with primary immunodeficiency diseases. Lancet. 1:610–611.
    1. Wardemann, H., T. Boehm, N. Dear, and R. Carsetti. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195:771–780.
    1. Liu, Y.J., F. Malisan, O. de Bouteiller, C. Guret, S. Lebecque, J. Banchereau, F.C. Mills, E.E. Max, and H. Martinez-Valdez. 1996. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity. 4:241–250.
    1. Weller, S., A. Faili, C. Garcia, M.C. Braun, F.F. Le Deist, G.G. de Saint Basile, O. Hermine, A. Fischer, C.A. Reynaud, and J.C. Weill. 2001. CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. Proc. Natl. Acad. Sci. USA. 98:1166–1170.
    1. Deenen, G.J., P.M. Dammers, T. de Boer, and F.G. Kroese. 1997. Identification of a novel rat B cell subset in the peritoneal cavity of xenogeneic rat to mouse SCID chimeras. Transplant. Proc. 29:1752–1753.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit